Recent advancements and clinical aspects of engineered iron oxide nanoplatforms for magnetic hyperthermia-induced cancer therapy
Materials Today Bio · 2024-12 · 29 · 101348
DOI: 10.1016/j.mtbio.2024.101348 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Materials Today Bio, 2024-12. Verfasst von Arunima Rajan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Flexible Electronics and Advanced Materials, Amrita Vishwa Vidyapeetham, Amritapuri, 690525, India. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 288 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amrita Vishwa Vidyapeetham University.
Abstract (Originalsprache)
The pervasiveness of cancer is a global health concern posing a major threat in terms of mortality and incidence rates. Magnetic hyperthermia (MHT) employing biocompatible magnetic nanoparticles (MNPs) ensuring selective attachment to target sites, better colloidal stability and conserving nearby healthy tissues has garnered widespread acceptance as a promising clinical treatment for cancer cell death. In this direction, multifunctional iron oxide nanoparticles (IONPs) are of significant interest for improved cancer care due to finite size effect associated with inherent magnetic properties. This review offers a comprehensive perception of IONPs-mediated MHT from fundamentals to clinical translation, by elucidating the underlying mechanism of heat generation and the related influential factors. Biological mechanisms underlying MHT-mediated cancer cell death such as reactive oxygen species generation and lysosomal membrane permeabilization have been discussed in this review. Recent advances in biological interactions (in vitro and in vivo) of IONPs and their translation to clinical MHT applications are briefed. New frontiers and prospects of promising combination cancer therapies such as MHT with photothermal therapy, cancer starvation therapy and sonodynamic therapy are presented in detail. Finally, this review concludes by addressing current crucial challenges and proposing possible solutions to achieve clinical success.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Flexible Electronics and Advanced Materials, Amrita Vishwa Vidyapeetham, Amritapuri, 690525, India.
- Centre for Nano Science and Engineering (CeNSE), Indian Institute of Science, Bangalore, 560012, India.
- Department of Materials Science and Engineering, Clemson University, Clemson, SC, 29634, USA.
- Centre for Nanotechnology Research, Vellore Institute of Technology, Vellore, 632014, India.
- Department of Physics, Bernal Institute and Limerick Digital Cancer Research Centre, University of Limerick, Castletroy, Limerick, V94T9PX, Ireland.
- Department of Mechanical Engineering, Amrita Vishwa Vidyapeetham, Amritapuri, 690525, India.
Förderung
- Amrita Vishwa Vidyapeetham University
Zitieren
APA
Rajan, A., Laha, S. S., Sahu, N. K., Thorat, N. D., & Shankar, B. (2024). Recent advancements and clinical aspects of engineered iron oxide nanoplatforms for magnetic hyperthermia-induced cancer therapy. Materials Today Bio, 29, 101348. https://doi.org/10.1016/j.mtbio.2024.101348
Vancouver
Rajan A, Laha SS, Sahu NK, Thorat ND, Shankar B. Recent advancements and clinical aspects of engineered iron oxide nanoplatforms for magnetic hyperthermia-induced cancer therapy. Materials Today Bio. 2024;29:101348. doi:10.1016/j.mtbio.2024.101348
BibTeX
@article{Rajan2024,
author = {Rajan, Arunima and Laha, Suvra S and Sahu, Niroj Kumar and Thorat, Nanasaheb D and Shankar, Balakrishnan},
title = {Recent advancements and clinical aspects of engineered iron oxide nanoplatforms for magnetic hyperthermia-induced cancer therapy},
journal = {Materials Today Bio},
year = {2024},
volume = {29},
pages = {101348},
doi = {10.1016/j.mtbio.2024.101348}
}
EUVIMED